Arcturus Therapeutics said it will showcase mRNA research in OTC deficiency at SSIEM 2026 in August, underscoring its focus on rare-disease therapies. The compa

BWB News TV • 2026-08-18 17:32 UTC • By Billy Odell Tucker-Robinson

Arcturus Therapeutics said it will showcase mRNA research in OTC deficiency at SSIEM 2026 in August, underscoring its focus on rare-disease therapies. The company has not specified whether new data or product updates will be presented.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly